Figure - available via license: Creative Commons Attribution 4.0 International
Content may be subject to copyright.
Figure S2. Tissue-niche analysis of breast cancer spatial transcriptomics data. Results of the expression-based clustering with resolution 0.2; visualization of the most-abundant cell type per spot based on cell2location deconvolution results, with and without epithelial cells. CAF: cancer-associated fibroblast; PVL: perivascular-like cells.
Source publication
Investigating tissue architecture is key to understanding tissue function in health and disease. While spatial omics technologies enable the study of cell transcriptomes within their native context, they often lack single-cell resolution. Deconvolution methods can computationally infer tissue composition from spatial transcriptomics data, but diffe...
Similar publications
This article reviews the transformative impact of single-cell whole genome sequencing (scWGS) on cancer biology research. ScWGS has revolutionized our understanding of tumor heterogeneity, clonal evolution, and the tumor microenvironment by enabling high-resolution analysis of individual cells' genomic, transcriptomic, and epigenomic profiles. The...
Citations
Cell-cell interaction (CCI) networks are key to understanding disease progression and treatment response. However, existing methods for inferring these networks often aggregate data across patients or focus on cell-type level interactions, providing a generalized overview but overlooking patient heterogeneity and local network structures. To address this, we introduce “random cell-cell interaction generator” (RaCInG), a model based on random graphs to derive personalized networks leveraging prior knowledge on ligand-receptor interactions and bulk RNA sequencing data. We applied RaCInG to 8,683 cancer patients to extract 643 network features related to the tumor microenvironment and unveiled associations with immune response and subtypes, enabling prediction and explanation of immunotherapy responses. RaCInG demonstrated robustness and showed consistencies with state-of-the-art methods. Our findings highlight RaCInG’s potential to elucidate patient-specific network dynamics, offering insights into cancer biology and treatment responses. RaCInG is poised to advance our understanding of complex CCI s in cancer and other biomedical domains.
